This stock is no longer traded. It was delisted on July 9, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
Summary of Jan 22's posts. Generated by AI.
Summary of Dec 23's posts. Generated by AI.
Summary of Dec 19's posts. Generated by AI.
Investors talking about PRPH also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
ProPhase Labs Inc. is a diversified health sciences company engaged in various segments of healthcare and diagnostics. The primary function of ProPhase Labs is to develop, manufacture, and market an array of over-the-counter (OTC) consumer healthcare products. The company has a crucial role in the health and wellness sector by providing innovative solutions for common ailments. Notably, ProPhase Labs also operates within the genetic testing and diagnostics space, offering services that cater to growing demands for personalized medicine and preventive healthcare measures. With a significant presence in both consumer products and advanced diagnostic services, ProPhase Labs impacts sectors ranging from retail healthcare to biotechnology. As a company continually expanding its product lines and diagnostic capabilities, ProPhase Labs positions itself as an integral player in fostering accessible health solutions, thereby enhancing its market significance in the dynamic landscape of healthcare innovation and delivery.
Website626 RXR Plaz
Uniondale, NY, 11556
United States